[vc_row][vc_column][vc_column_text]

With over 97,270 brand launches and exports (led by the US market) the Indian pharmaceutical market has grown to almost double in the last decade.

The US Market Alliance Turns out a Game Changer

The most significant contributor to the growth of the industry is the US generics business. According to Pankaj Patel, chairman of Cadila Healthcare, “the US has been the only growth driver for Indian pharma firms in the last decade. The domestic market is clocking a healthy growth rate of around 12% or so”.

The US Food and Drug Administration (USFDA) approved 304 Abbreviated New Drug Application (ANDA) for Indian companies. The country accounts for around 30% (by volume) and about 10% (value) in the $70-80 billion US generics market.

Indian companies shifted their focus to the US drug market around 10 years ago and Sun Pharma was the frontrunner. It penetrated the market way back in 2008-2009 after acquiring Caraco Pharmaceutical Laboratories. The success of Sun Pharma in the US market is both an inspiration and an indicator of opportunities other Indian companies have here.

In May 2015, the Indian Pharmaceutical Alliance (IPA) created a forum for data reliability development, investigation, process validation, and good documentation practices. The forum led by six chief executive officers has turned out to be a huge success with India’s warning letters coming down to 29%.

Recent Developments

• Between Jul-Sep 2018, the Indian pharma sector witnessed 39 PE investment deals worth $217 million. 
• Investment (as % of sales) in research & development by Indian pharma companies increased from 5.3% in FY12 to 8.5% in FY18. 
• In 2017, the Indian pharmaceutical sector witnessed 46 M&A deals worth $1.47 billion. 
• From 2018-19, India’s pharmaceuticals exports have set the verge of US$ 19.13 billion with an exponential growth of 10.72% over $17.28 billion as compared to pharma exports last year.

The Indian pharmaceutical industry has undergone a magnificent journey as a whole in the last 10 years. The industry is poised to achieve more success in the future as well with medicine spending is projected to grow 9-12% over the next five years. The growth graph of the last decade clearly indicates that the Indian pharmaceutical industry is a hub of opportunities for investors.

Contact the most trusted pharma consultants in india make your business journey to the country successful with high-returns and no risks.

[/vc_column_text][/vc_column][/vc_row]